Condition: Chemotherapy-induced Peripheral Neuropathy · Sponsor: Jessa Hospital
This study aims to investigate the effectiveness of photobiomodulation therapy (PBM) in the management of chemotherapy-induced peripheral neuropathy (CIPN). Therefore, the hypothesis is that PBM can reduce the severity of CIPN in cancer patients, increasing the patient's quality of life.
This description comes directly from the study's public registry record.
Jeroen Mebis, Prof. Dr. · 011 33 72 21 · jeroen.mebis@jessazh.be
Marithé Claes, MSc · 011 33 72 39 · marithe.claes@uhasselt.be
Always discuss trial participation with your own doctor first.
| Jessa Hospital | Hasselt, Limburg, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05763706